Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis

BACKGROUND: A pathological complete response (pCR) after neoadjuvant chemotherapy (NCT) is a strong indicator of the benefit of therapy and presents an early surrogate for a favorable long-term outcome. It remains unclear whether Ki-67, a marker for tumor proliferation, can function as a predictor o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Miaomiao, Chen, Shu, Zhang, Xianquan, Zhou, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758242/
https://www.ncbi.nlm.nih.gov/pubmed/29390540
http://dx.doi.org/10.1097/MD.0000000000009384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758242/
https://www.ncbi.nlm.nih.gov/pubmed/29390540
http://dx.doi.org/10.1097/MD.0000000000009384

Ejemplares similares